Clinical Trial Update: Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of iodine-131 tositumomab followed by autologous stem cell transplantation. The study in older patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Bexxar (tositumomab) with Iodine-131 (tositumomab)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED